Journal profile · Medicine-General Medicine
MedComm - Future Medicine
ISSN 2769-6456 · Wiley · Australia
MedComm - Future Medicine: fully open access; APC about USD 2,600; median 114 days to acceptance (68 articles, last 24 months); acceptance rate 35% (journal website); 44 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
MedComm - Future Medicine is published by Wiley. By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Artificial Intelligence in Healthcare and Education and COVID-19 Clinical Research Studies, together about 22.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aim of the journal MedComm – Future Medicine is a peer-reviewed open access journal that publishes high quality research in medicine and biology on the basis of novelty, timeliness and significance to human health and diseases. It covers the latest advances in biomedical research and healthcare delivery that will address unmet medical needs and transform future medical therapies. These include demonstration of technological innovations (including screening, diagnosis, prevention and treatment) and novel interventions for human diseases with potential for future clinical translation. Scope and topics MedComm – Future Medicine is a multidisciplinary journal covering topics of interest, including multiomics, bioinformatics, medical artificial intelligence (AI), stem cell and regenerative medicine, gene editing and therapy, relating to major human health and diseases, including but not limited to cancer, cardiovascular diseases, autoimmune diseases, nervous system diseases, and aging. MedComm – Future Medicine focuses on the discovery of novel disease mechanisms and application of cutting-edge technologies to meet medical challenges. Relevant topics include, but are not limited to, development of ground-breaking technologies and therapies, interdisciplinary approaches, application of big data and AI in healthcare delivery, and precision medicine for early detection and outcome prediction for major diseases. Indexing information: CAS: Chemical Abstracts Service (ACS) Directory of Open Access Journals (DOAJ) SCOPUS (Elsevier)
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief Robin AliPublisher website
Editorial board by country: 11 in mainland China (about 31%); most named Mainland China 11, United States 10, Macau, China 5, United Kingdom 5, Hong Kong, China 1 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine10.5%
- Artificial Intelligence in Healthcare and EducationMedicine6.4%
- COVID-19 Clinical Research StudiesMedicine5.9%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.9%
- Computational Drug Discovery MethodsComputer Science5.9%
- Mesenchymal stem cell researchMedicine5.3%
- Ferroptosis and cancer prognosisMedicine4.1%
- Radiomics and Machine Learning in Medical ImagingMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q1 | 135/669 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher) 2025
- 3.9Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 0.44LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 2.29OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher) 2025
- 36Publisher website ·
- Downloads per year (publisher) 2025
- 82,026Publisher website ·
Articles by year OpenAlex count · 201 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 45 | 292 |
| 2025 | 44 | 44 | 279 |
| 2024 | 45 | 45 | 183 |
| 2023 | 44 | 44 | 64 |
| 2022 | 23 | 23 | 7 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
113 daysMedian, submission to acceptance · P25–P75 60 days – 156 days
- Acceptance to online
- median 18 days (85 articles)
- Submission to online
- median 143 days
- Sample
- 63 articles with submission and acceptance dates (77 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Acceptance rate (publisher) 2025
- 35%Publisher website ·
- Submission to first decision 2025
- 14 daysPublisher website ·
- Submission to acceptance 2025
- 104 daysPublisher website ·
- Acceptance to publication 2025
- 24 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,254 / GBP 1,912 / USD 2,600 | Yes | CC BY | |
| OpenAlex | USD 0 | — | — | |
| LetPub | USD 2,600 | Yes | — | |
| Publisher website | No APC | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Manuscript length
- ≤ 6,000 words
- Reference style
- AMA
- Suggested reviewers
- Optional
- Graphical abstract
- Required
Article types accepted12, with length limits
- editorialOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 1,000 words
- editorialsEditorials are the most important statement and opinions of global opinion leaders in relevant specialties and specially invited by the Editor, but unsolicited …Length not stated
- highlightHighlight aims to point the MedComm - Future Medicine readership to the latest novel findings published in other high-impact journals.Length not stated
- letterOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 1,200 words
- opinionOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- original articleOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- perspectiveOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 3,000 words
- perspectivesPerspectives discuss published findings and ideas from a personal viewpoint.Length not stated
- research articleOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 6,000 words
- reviewOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- systematic reviewOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- viewpointOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship and Author Contribution
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Pot…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Please review Wiley’s policy here. This journal encourages data sharing.
Source ↗Publisher website ·- License & copyright
Licensing: CC BY - Creative Commons Attribution License. Model summary
Accepted papers will be published under CC BY - Creative Commons Attribution License.
Source ↗Publisher website ·- Open access Understanding Open Access
As an open access journal, all articles in MedComm – Future Medicine are freely available to read, download and share immediately on publication.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Peer review: single-blind peer reviewed by two reviewers. Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two reviewers. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Preprints
Preprint policy: This journal considers article previously published on preprint servers. Model summary
MedComm - Future Medicine will consider for review articles previously available as preprints.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- Australia
- Language
- English
- ISSN
- 2769-6456
- Society / sponsor
- Sichuan International Medical Exchange & Promotion Association
- Latest issue on the website
- Volume 5, Issue 3 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about MedComm - Future Medicine
How long does peer review take at MedComm - Future Medicine?
Based on the dates recorded on 68 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 114 days (interquartile range 63–153 days); authors report an average review time of about 15 weeks; the journal's website gives an acceptance rate of 35% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of MedComm - Future Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Manuscript length: ≤ 6,000 words; Reference style: AMA; Suggested reviewers: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of MedComm - Future Medicine based?
Of the 36 board members whose country the journal's board page names, 11 (about 31%) are in mainland China; the countries named most often are Mainland China (11), United States (10) and Macau, China (5). Counted from the institutions listed on the board page; for reference only.
Which databases index MedComm - Future Medicine?
According to LetPub and DOAJ records, MedComm - Future Medicine is indexed in Scopus and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.
Is MedComm - Future Medicine open access, and what is the APC?
MedComm - Future Medicine is a fully open-access journal. APC about USD 2,600.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .